Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pyoderma.

F M Novice, P Hacker, W P Unger

    International Journal of Dermatology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Malignant pyoderma, a rare skin condition, was successfully treated with cyclophosphamide. This immunosuppressive therapy achieved complete remission in a patient resistant to other treatments.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reply.

    Arthritis & rheumatology (Hoboken, N.J.)·2021
    Same author

    Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis.

    Arthritis & rheumatology (Hoboken, N.J.)·2020
    Same author

    Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.

    Scandinavian journal of rheumatology·2020
    Same author

    Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort.

    ACR open rheumatology·2019
    Same author

    Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis.

    ACR open rheumatology·2019
    Same author

    HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications.

    Scientific reports·2016
    Same journal

    The "Stamp-n-Tack" Technique: An Ink-Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction.

    International journal of dermatology·2026
    Same journal

    Counterfactual Dermatology With Generative Models.

    International journal of dermatology·2026
    Same journal

    Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus Patients.

    International journal of dermatology·2026
    Same journal

    Paracetamol-Induced Generalized Bullous Fixed Drug Eruption With Positive Anti-BP230 Antibody and Confirmed With Oral Provocation Test in a Child: A Case Report From the Philippines.

    International journal of dermatology·2026
    Same journal

    Clinicopathological Challenge: A Painful Violaceous Reticulated Patch.

    International journal of dermatology·2026
    Same journal

    Editor's Highlights-August 2026.

    International journal of dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Immunosuppression
    • Oncology

    Background:

    • Malignant pyoderma is a rare, ulcerative skin disease often associated with underlying systemic conditions.
    • Treatment options for malignant pyoderma are limited and often involve a multidisciplinary approach.

    Observation:

    • A case report details a patient with malignant pyoderma refractory to multiple therapies.
    • The patient presented with characteristic ulcerative lesions and systemic involvement.

    Findings:

    • Complete remission was achieved using immunosuppressive cyclophosphamide therapy.
    • Cyclophosphamide demonstrated efficacy in a treatment-resistant malignant pyoderma case.

    Implications:

    • Cyclophosphamide represents a viable therapeutic option for refractory malignant pyoderma.
    • Further research into immunosuppressive agents for pyoderma is warranted.